AlloSource to Highlight Early Findings of ProChondrix Cartilage Restoration Matrix at International Cartilage Repair Society Symposia

AlloSource will share early results of its fresh cartilage allograft, ProChondrix®, duringAllo_ESPN_skysc-banner_160x600_04-16 the International Cartilage Repair Society’s (ICRS) 13th World Congress in Sorrento-Naples Italy.  The Industry Satellite Lunch Symposia will take place on Monday, 26 September 2016 from 13:00 to 13:30 in the Sala Nettuna Room.

Vishal Mehta, M.D., orthopedic surgeon from Fox Valley Orthopedics in Geneva, Illinois, will present early results of ProChondrix transplantation on isolated articular cartilage defects.  Patients underwent treatment of an isolated, symptomatic articular cartilage surface lesion, which was treated with microfracture and placement of a ProChondrix graft.  The 12-month review post-treatment demonstrated early success and no failures.  In addition to Dr. Metha, Laurie Goodrich, D.V.M, Ph. D., associate professor in equine surgery and lameness at Colorado State University, will share the findings of a 12-month horse study.

AlloSource will also present several posters at ICRS.  One will focus on Dr. Mehta’s 12-month clinical results, another highlights Dr. Goodrich’s equine study findings, both previously mentioned, and another poster shares results from an internal study on ProChondrix’s likeness to healthy adult cartilage.

For more information on ProChondrix and the recently launched Reimbursement Hotline dedicated to assisting customers and providing information on coding options, coverage access and reimbursement, please visit ProChondrix.org.

AlloSource will share early results of its fresh cartilage allograft, ProChondrix®, during the International Cartilage Repair Society’s (ICRS) 13th World Congress in Sorrento-Naples Italy.  The Industry Satellite Lunch Symposia will take place on Monday, 26 September 2016 from 13:00 to 13:30 in the Sala Nettuna Room.

Vishal Mehta, M.D., orthopedic surgeon from Fox Valley Orthopedics in Geneva, Illinois, will present early results of ProChondrix transplantation on isolated articular cartilage defects.  Patients underwent treatment of an isolated, symptomatic articular cartilage surface lesion, which was treated with microfracture and placement of a ProChondrix graft.  The 12-month review post-treatment demonstrated early success and no failures.  In addition to Dr. Metha, Laurie Goodrich, D.V.M, Ph. D., associate professor in equine surgery and lameness at Colorado State University, will share the findings of a 12-month horse study.

AlloSource will also present several posters at ICRS.  One will focus on Dr. Mehta’s 12-month clinical results, another highlights Dr. Goodrich’s equine study findings, both previously mentioned, and another poster shares results from an internal study on ProChondrix’s likeness to healthy adult cartilage.

For more information on ProChondrix and the recently launched Reimbursement Hotline dedicated to assisting customers and providing information on coding options, coverage access and reimbursement, please visit ProChondrix.org.